| Analyst | Price Target | Date |
|---|---|---|
| Nordea | 30 SEK | Nov -25 |
| SEB | 32 SEK | May -25 |
| SEB Equities | 30 SEK | Sep -24 |
| Danske Bank | 61 SEK | Feb -24 |
Genovis was founded in 1999 by Sarah Fredriksson, who was CEO of Genovis until May 2015, when she became chairman of the board. The business was initially focused on nanoparticles intended for both the preclinical and clinical market.
Genovis